The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
Open accessAbstract
THIS REPORT UPDATES THE 2021-22 RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) CONCERNING THE USE OF SEASONAL INFLUENZA VACCINES IN THE UNITED STATES: (MMWR Recomm Rep 2021;70[No. RR-5]:1-24). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. With the exception of vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. All seasonal influenza vaccines expected to be available in the United States for the 2022-23 season are quadrivalent, containing hemagglutinin (HA) derived from one influenza A(H1N1)pdm09 virus, one influenza A(H3N2) virus, one influenza B/Victoria lineage virus, and one influenza B/Yamagata lineage virus. Inactivated influenza vaccines (IIV4s), recombinant influenza vaccine (RIV4), and live attenuated influenza vaccine (LAIV4) are expected to be available. Trivalent influenza vaccines are no longer available, but data that involve these vaccines are included for reference. INFLUENZA VACCINES MIGHT BE AVAILABLE AS EARLY AS JULY OR AUGUST, BUT FOR MOST PERSONS WHO NEED ONLY 1 DOSE OF INFLUENZA VACCINE FOR THE SEASON, VACCINATION SHOULD IDEALLY BE OFFERED DURING SEPTEMBER OR OCTOBER. HOWEVER, VACCINATION SHOULD CONTINUE AFTER OCTOBER AND THROUGHOUT THE SEASON AS LONG AS INFLUENZA VIRUSES ARE CIRCULATING AND UNEXPIRED VACCINE IS AVAILABLE. FOR MOST ADULTS (PARTICULARLY ADULTS AGED ≥65 YEARS) AND FOR PREGNANT PERSONS IN THE FIRST OR SECOND TRIMESTER, VACCINATION DURING JULY AND AUGUST SHOULD BE AVOIDED UNLESS THERE IS CONCERN THAT VACCINATION LATER IN THE SEASON MIGHT NOT BE POSSIBLE. CERTAIN CHILDREN AGED 6 MONTHS THROUGH 8 YEARS NEED 2 DOSES; THESE CHILDREN SHOULD RECEIVE THE FIRST DOSE AS SOON AS POSSIBLE AFTER VACCINE IS AVAILABLE, INCLUDING DURING JULY AND AUGUST. VACCINATION DURING JULY AND AUGUST CAN BE CONSIDERED FOR CHILDREN OF ANY AGE WHO NEED ONLY 1 DOSE FOR THE SEASON AND FOR PREGNANT PERSONS WHO ARE IN THE THIRD TRIMESTER IF VACCINE IS AVAILABLE DURING THOSE MONTHS: UPDATES DESCRIBED IN THIS REPORT REFLECT DISCUSSIONS DURING PUBLIC MEETINGS OF ACIP THAT WERE HELD ON OCTOBER 20, 2021; JANUARY 12, 2022; FEBRUARY 23, 2022; AND JUNE 22, 2022. PRIMARY UPDATES TO THIS REPORT INCLUDE THE FOLLOWING THREE TOPICS: 1) THE COMPOSITION OF 2022-23 U.S. SEASONAL INFLUENZA VACCINES; 2) UPDATES TO THE DESCRIPTION OF INFLUENZA VACCINES EXPECTED TO BE AVAILABLE FOR THE 2022-23 SEASON, INCLUDING ONE INFLUENZA VACCINE LABELING CHANGE THAT OCCURRED AFTER THE PUBLICATION OF THE 2021-22 ACIP INFLUENZA RECOMMENDATIONS; AND 3) UPDATES TO THE RECOMMENDATIONS CONCERNING VACCINATION OF ADULTS AGED ≥65 YEARS. FIRST, THE COMPOSITION OF 2022-23 U.S. INFLUENZA VACCINES INCLUDES UPDATES TO THE INFLUENZA A(H3N2) AND INFLUENZA B/VICTORIA LINEAGE COMPONENTS. U.S.-LICENSED INFLUENZA VACCINES WILL CONTAIN HA DERIVED FROM AN INFLUENZA A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE VIRUS (FOR EGG-BASED VACCINES) OR AN INFLUENZA A/WISCONSIN/588/2019 (H1N1)PDM09-LIKE VIRUS (FOR CELL CULTURE-BASED OR RECOMBINANT VACCINES); AN INFLUENZA A/DARWIN/9/2021 (H3N2)-LIKE VIRUS (FOR EGG-BASED VACCINES) OR AN INFLUENZA A/DARWIN/6/2021 (H3N2)-LIKE VIRUS (FOR CELL CULTURE-BASED OR RECOMBINANT VACCINES); AN INFLUENZA B/AUSTRIA/1359417/2021 (VICTORIA LINEAGE)-LIKE VIRUS; AND AN INFLUENZA B/PHUKET/3073/2013 (YAMAGATA LINEAGE)-LIKE VIRUS. SECOND, THE APPROVED AGE INDICATION FOR THE CELL CULTURE-BASED INACTIVATED INFLUENZA VACCINE, FLUCELVAX QUADRIVALENT (CCIIV4), WAS CHANGED IN OCTOBER 2021 FROM ≥2 YEARS TO ≥6 MONTHS. THIRD, RECOMMENDATIONS FOR VACCINATION OF ADULTS AGED ≥65 YEARS HAVE BEEN MODIFIED. ACIP RECOMMENDS THAT ADULTS AGED ≥65 YEARS PREFERENTIALLY RECEIVE ANY ONE OF THE FOLLOWING HIGHER DOSE OR ADJUVANTED INFLUENZA VACCINES: QUADRIVALENT HIGH-DOSE INACTIVATED INFLUENZA VACCINE (HD-IIV4), QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (RIV4), OR QUADRIVALENT ADJUVANTED INACTIVATED INFLUENZA VACCINE (AIIV4). IF NONE OF THESE THREE VACCINES IS AVAILABLE AT AN OPPORTUNITY FOR VACCINE ADMINISTRATION, THEN ANY OTHER AGE-APPROPRIATE INFLUENZA VACCINE SHOULD BE USED: THIS REPORT FOCUSES ON RECOMMENDATIONS FOR THE USE OF VACCINES FOR THE PREVENTION AND CONTROL OF SEASONAL INFLUENZA DURING THE 2022-23 INFLUENZA SEASON IN THE UNITED STATES. A BRIEF SUMMARY OF THE RECOMMENDATIONS AND A LINK TO THE MOST RECENT BACKGROUND DOCUMENT CONTAINING ADDITIONAL INFORMATION ARE AVAILABLE AT: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html. These recommendations apply to U.S.-licensed influenza vaccines used according to Food and Drug Administration-licensed indications. Updates and other information are available from CDC's influenza website (https://www.cdc.gov/flu). Vaccination and health care providers should check this site periodically for addition
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,077
Self-citationGrohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Effectiveness of maternal influenza immunization in mothers and infants
Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R., Wilson, E., Omer, S. B., Shahid, N. S., Breiman, R. F., & Steinhoff, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708630 · Cited by 1,227
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876 · cited 1×
“HD-IIV3 was more effective than SD-IIV3 in prevention of polymerase chain reaction (PCR)- or culture-confirmed influenza-like illness (ILI) in a two-season randomized study conducted among 32,000 persons aged ≥65 years (relative efficacy: 24%; 95% CI: 10%–36%; certainty level: 1, high) (66).”
BackgroundSelf-citationThe Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
Influenza vaccination of pregnant women and protection of their infants
Madhi, S. A., Cutland, C. L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., Adrian, P. V., van Niekerk, N., Treurnicht, F., Ortiz, J. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401480 · Cited by 556
Pearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
(2011) · PubMed · Cited by 424
Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388
IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Grohskopf, L. A., Alyanak, E., Ferdinands, J. M., Broder, K. R., Blanton, L. H., Talbot, H. K., & Fry, A. M. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7005a1 · Cited by 360
Self-citationRolfes, M. A., Foppa, I. M., Garg, S., Flannery, B., Brammer, L., Singleton, J. A., Burns, E., Jernigan, D., Olsen, S. J., Bresee, J., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12486 · Cited by 310
Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants
Eick, A. A., Uyeki, T. M., Klimov, A., Hall, H., Reid, R., Santosham, M., & O’Brien, K. L. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.192 · Cited by 302
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 297
Self-citationEfficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608862 · Cited by 291
Barker, W. H. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.761 · Cited by 290
Tapia, M. D., Sow, S. O., Tamboura, B., Tégueté, I., Pasetti, M. F., Kodio, M., Onwuchekwa, U., Tennant, S. M., Blackwelder, W. C., Coulibaly, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30054-8 · Cited by 245
Influenza- and RSV-associated hospitalizations among adults
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, L. A., Black, S., & Shay, D. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.041 · Cited by 235
Steinhoff, M. C., Katz, J., Englund, J. A., Khatry, S. K., Shrestha, L., Kuypers, J., Stewart, L., Mullany, L. C., Chu, H. Y., LeClerq, S. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30252-9 · Cited by 227
Kissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J. G., Flannery, B., Jackson, M. L., & Belongia, E. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw816 · Cited by 195
Self-citationNeuzil, K. M., Jackson, L. A., Nelson, J., Klimov, A., Cox, N., Bridges, C. B., Dunn, J., DeStefano, F., & Shay, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/507309 · Cited by 191
The Burden of Influenza in Young Children, 2004–2009
Poehling, K. A., Edwards, K. M., Griffin, M. R., Szilagyi, P. G., Staat, M. A., Iwane, M. K., Snively, B. M., Suerken, C. K., Hall, C. B., Weinberg, G. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1255 · Cited by 183
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Izurieta, H. S., Thadani, N., Shay, D. K., Lu, Y., Maurer, A., Foppa, I. M., Franks, R., Pratt, D., Forshee, R. A., MaCurdy, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71087-4 · Cited by 181
Gravenstein, S., Davidson, H. E., Taljaard, M., Ogarek, J., Gozalo, P., Han, L., & Mor, V. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30235-7 · Cited by 176
Pebody, R. G., Andrews, N., McMenamin, J., Durnall, H., Ellis, J., Thompson, C. I., Robertson, C., Cottrell, S., Smyth, B., Zambon, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20389-en · Cited by 163
Izurieta, H. S., Chillarige, Y., Kelman, J., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Chu, S., Wernecke, M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy716 · Cited by 163
Castilla, J., Martínez‐Baz, I., Martínez-Artola, V., Reina, G., Pozo, F., Cenoz, M. G., Guevara, M., Moran, J., Irisarri, F., Arriazu, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20388-en · Cited by 162
Seasonal influenza vaccine in immunocompromised persons
Bosaeed, M., & Kumar, D. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1445446 · Cited by 158
Young, B. E., Sadarangani, S. P., Jiang, L., Wilder‐Smith, A., & Chen, M. I.-C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix632 · Cited by 157
McMillan, M., Porritt, K. A., Kralik, D., Costi, L., & Marshall, H. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.068 · Cited by 155
Vardeny, O., Kim, K., Udell, J. A., Joseph, J., Desai, A. S., Farkouh, M. E., Hegde, S. M., Hernandez, A. F., McGeer, A., Talbot, H. K., et al. (2020) · JAMA · doi:10.1001/jama.2020.23649 · Cited by 153
Self-citationBelongia, E. A., Sundaram, M. E., McClure, D. L., Meece, J. K., Ferdinands, J. M., & VanWormer, J. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.052 · Cited by 152
Self-citationFrey, S. E., Reyes, M. R. A.-D. L., Reynales, H., Bermal, N., Nicolay, U., Narasimhan, V., Forleo‐Neto, E., & Arora, A. K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.013 · Cited by 145
Kissling, E., Nunes, B., Robertson, C., Valenciano, M., Reuß, A., Larrauri, A., Cohen, J. M., Oroszi, B., Rizzo, C., Machado, A., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.16.30201 · Cited by 145
Coleman, B. L., Fadel, S. A., Fitzpatrick, T., & Thomas, S.-M. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12504 · Cited by 145
Bratton, K. N., Wardle, M. T., Orenstein, W. A., & Omer, S. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu915 · Cited by 143
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
Mütsch, M., Tavernini, M., Marx, A., Gregory, V., Lin, Y. P., Hay, A. J., Tschopp, A., & Steffen, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/429243 · Cited by 136
Eisenberg, K. W., Szilagyi, P. G., Fairbrother, G., Griffin, M. R., Staat, M. A., Shone, L. P., Weinberg, G. A., Hall, C. B., Poehling, K. A., Edwards, K. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3304 · Cited by 133
DiazGranados, C. A., Robertson, C. A., Talbot, H. K., Landolfi, V. A., Dunning, A. J., & Greenberg, D. P. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.006 · Cited by 125
Self-citationIntraseason Waning of Influenza Vaccine Effectiveness
Ray, G. T., Lewis, N., Klein, N. P., Daley, M. F., Wang, S. V., Kulldorff, M., & FIREMAN, B. H. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy770 · Cited by 122
Pasternak, B., Svanström, H., Mølgaard‐Nielsen, D., Krause, T. G., Emborg, H., Melbye, M., & Hviid, A. P. (2012) · BMJ · doi:10.1136/bmj.e2794 · Cited by 121
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Allison, M. A., Daley, M. F., Crane, L. A., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.036 · Cited by 121
ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002588 · Cited by 121
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., Weintraub, E., Vazquez‐Benitez, G., McNeil, M. M., Li, R., Klein, N. P., Hambidge, S. J., Naleway, A. L., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001066 · Cited by 117
Donahue, J. G., Kieke, B. A., King, J. P., Destefano, F. R., Mascola, M. A., Irving, S. A., Cheetham, T. C., Glanz, J. M., Jackson, L. A., Klein, N. P., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.069 · Cited by 112
Izikson, R., Brune, D., Bolduc, J.-S., Bourron, P., Fournier, M., Moore, T. M., Pandey, A., Perez, L., Sater, N., Shrestha, A., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00557-9 · Cited by 112
Chambers, C., Johnson, D., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.097 · Cited by 111
Shay, D. K., Chillarige, Y., Kelman, J. A., Forshee, R. A., Foppa, I., Wernecke, M., Lu, Y., Ferdinands, J. M., Iyengar, A., Fry, A. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw641 · Cited by 107
Self-citationSafety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
Heikkinen, T., Young, J., van Beek, E., Franke, H. R., Verstraeten, T., Weil, J., & Cioppa, G. D. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.007 · Cited by 104
Kerzner, B., Murray, A. V., Cheng, E., Ifle, R., Harvey, P. R., Tomlinson, M., Barben, J. L., Rarrick, K., Stek, J. E., Chung, M., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01397.x · Cited by 96
Patterson, J. L., Carapetian, S., Hageman, J. R., et al. (2013) · Pediatric Annals · doi:10.3928/00904481-20131122-09 · Cited by 95
Schwarz, T. F., Flamaing, J., Rümke, H. C., Pénzes, J., Juergens, C., Wenz, A., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.031 · Cited by 94
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019
Izurieta, H. S., Chillarige, Y., Kelman, J. A., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Wernecke, M., MaCurdy, T. E., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa080 · Cited by 93
Izurieta, H. S., Lu, M., Kelman, J. A., Lu, Y., Lindaas, A., Loc, J., Pratt, D., Wei, Y., Chillarige, Y., Wernecke, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1727 · Cited by 92
Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion
Irving, S. A., Kieke, B. A., Donahue, J. G., Mascola, M. A., Baggs, J. M., Destefano, F. R., Cheetham, T. C., Jackson, L. A., Naleway, A. L., Glanz, J. M., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318279f56f · Cited by 88
A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy
Oppermann, M., Fritzsche, J., Weber‐Schoendorfer, C., Keller‐Stanislawski, B., Allignol, A., Meister, R., & Schaefer, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.081 · Cited by 84
Fragaszy, E., Warren‐Gash, C., White, P. J., Zambon, M. C. F. A., Edmunds, W. J., Nguyen‐Van‐Tam, J. S., Hayward, A. C., & on behalf of the Flu Watch Group (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12506 · Cited by 83
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Duffy, J., Weintraub, E., Hambidge, S. J., Jackson, L. A., Kharbanda, E. O., Klein, N. P., Lee, G. M., Marcy, S. M., Nakasato, C. C., Naleway, A. L., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0320 · Cited by 78
Schwarz, T. F., Aggarwal, N., Moeckesch, B., Schenkenberger, I., Claeys, C., Douha, M., Godeaux, O., Grupping, K., Heineman, T. C., López‐Fauqued, M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix481 · Cited by 78
Large Summertime Influenza A Outbreak among Tourists in Alaska and the Yukon Territory
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K., Buxton, J. A., Miller, J. M., Beller, M. J., Butler, J. C., Fukuda, K., Maloney, S. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374053 · Cited by 76
Chambers, C., Johnson, D. L., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.054 · Cited by 76
Young‐Xu, Y., van Aalst, R., Mahmud, S. M., Rothman, K. J., Snider, J. T., Westreich, D. J., Mor, V., Gravenstein, S., Lee, J. K. H., Thommes, E. W., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy088 · Cited by 74
Frenck, R. W., Gurtman, A., Rubino, J., Smith, W., van Cleeff, M., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., Scott, D. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-12 · Cited by 73
Lum, L. C. S., Borja-Tabora, C., Breiman, R. F., Vesikari, T., Sablan, B. P., Chay, O. M., Tantracheewathorn, T., Schmitt, H.-J., Lau, Y., Bowonkiratikachorn, P., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.054 · Cited by 70
Richardson, D. M., Medvedeva, E. L., Roberts, C. B., & Linkin, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ261 · Cited by 68
Keitel, W., Treanor, J. J., Sahly, H. M. E., Gilbert, A., Meyer, A. L., PATRIARCA, P. A., & Cox, M. M. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.037 · Cited by 64
Ferdinands, J. M., Gaglani, M., Martin, E. T., Monto, A. S., Middleton, D. B., Silveira, F. P., Talbot, H. K., Zimmerman, R. K., & Patel, M. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab045 · Cited by 62
Self-citationWaning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
Puig‐Barberà, J., Mira‐Iglesias, A., Tortajada‐Girbés, M., López‐Labrador, F. X., Librero, J., Díez‐Domingo, J., Carballido‐Fernández, M., Carratalá‐Munuera, C., Medina, P. C., Gil-Guillén, V. F., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.035 · Cited by 61
van Aalst, R., Gravenstein, S., Mor, V., Mahmud, S. M., Wilschut, J., Postma, M. J., & Chit, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.105 · Cited by 61
Donahue, J. G., Kieke, B. A., King, J. P., Mascola, M. A., Shimabukuro, T. T., DeStefano, F., Hanson, K. E., McClure, D. L., Olaiya, O., Glanz, J. M., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.035 · Cited by 59 · cited 1×
“However, in a larger VSD follow-up study, IIV was not associated with an increased risk for miscarriage during the 2012–13, 2013–14, and 2014–15 seasons, regardless of previous season vaccination (63).”
BackgroundStockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 57
Self-citationRadin, J. M., Hawksworth, A. W., Myers, C. A., Ricketts, M. N., Hansen, E. A., & Brice, G. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.034 · Cited by 55
The impact of influenza infection on young children, their family and the health care system
Willis, G. A., Preen, D. B., Richmond, P., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12604 · Cited by 53
Sammon, C., Snowball, J. M., McGrogan, A., & de Vries, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051734 · Cited by 52
Influenza and Workplace Productivity Loss in Working Adults
Wormer, J. J. V., King, J. P., Gajewski, A., et al. (2017) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001120 · Cited by 52
Nolan, T. M., Bernstein, D. I., Block, S. L., Hilty, M. D., KEYSERLING, H. L., Marchant, C. D., Marshall, H. S., Richmond, P., Yogev, R., Cordova, J. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1064 · Cited by 49
Ferdinands, J. M., Alyanak, E., Reed, C., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz452 · Cited by 48
Self-citationMillman, A. J., Duong, K. K., Lafond, K. E., Green, N. M., Lippold, S. A., & Jhung, M. A. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12215 · Cited by 47
McConeghy, K. W., Davidson, H. E., Canaday, D. H., Han, L., Saade, E., Mor, V., & Gravenstein, S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1233 · Cited by 47
Li, R., Stewart, B., McNeil, M. M., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3996 · Cited by 42
Pelton, S. I., Divino, V. M., Shah, D., Mould-Quevedo, J. F., DeKoven, M., Krishnarajah, G., & Postma, M. J. (2020) · Vaccines · doi:10.3390/vaccines8030446 · Cited by 42
Ratnam, I., Black, J., Leder, K. S., Biggs, B., Gordon, I., Matchett, E., Padiglione, A. A., Woolley, I. J., Karapanagiotidis, T., Gherardin, T., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.01.008 · Cited by 40
Young‐Xu, Y., Snider, J. T., van Aalst, R., Mahmud, S. M., Thommes, E. W., Lee, J. K. H., Greenberg, D. P., & Chit, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.063 · Cited by 36
Song, J. Y., Cheong, H. J., Tsai, T. F., Chang, H.-A., Choi, M. J., Jeon, J. H., Kang, S. H., Jeong, E. J., Noh, J. Y., & Kim, W. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.003 · Cited by 34
Lu, Y., Chillarige, Y., Izurieta, H. S., Wei, Y., Xu, W., Lu, M., Sung, H.-M., Lindaas, A., Wernecke, M., MaCurdy, T. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz360 · Cited by 33
McNeil, S., Noya, F., Dionne, M., Predy, G., Meekison, W., Ojah, C., Ferro, S., Mills, E. L., Langley, J. M., & Halperin, S. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.047 · Cited by 31
Huang, W., Tang, F.-W., Yang, S.-E., Chih, Y.-C., & Chuang, J.-H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.054 · Cited by 30
Pelton, S. I., Divino, V. M., Postma, M. J., Shah, D., Mould-Quevedo, J. F., DeKoven, M., & Krishnarajah, G. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.054 · Cited by 29
Schmader, K. E., Liu, C., Harrington, T. A., Rountree, W., Auerbach, H., Walter, E. B., Barnett, E. D., Schlaudecker, E. P., Todd, C. A., Poniewierski, M. S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.31266 · Cited by 28
Self-citationLevin, M. J., Buchwald, U. K., Gardner, J. E., Martin, J. C., Stek, J. E., Brown, E., & Popmihajlov, Z. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.029 · Cited by 27
Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women
Ma, F., Zhang, L., Jiang, R., et al. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00375-14 · Cited by 23
Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness
Young, B. E., Mak, T. M., Ang, L. W., Sadarangani, S. P., Ho, H. J. A., Wilder‐Smith, A., Barkham, T., & Chen, M. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002952 · Cited by 21
Nakashima, K., Aoshima, M., Ohfuji, S., Yamawaki, S., Nemoto, M., Hasegawa, S., Noma, S., Misawa, M., Hosokawa, N., Yaegashi, M., et al. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1455476 · Cited by 20
Lu, Y., Chillarige, Y., Izurieta, H. S., Wei, Y., Xu, W., Lu, M., Sung, H.-M., Lindaas, A., Wernecke, M., MaCurdy, T. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz463 · Cited by 20
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations
Walter, E. B., Klein, N. P., Wodi, A. P., et al. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1909 · Cited by 18
Ng, Y., Nandar, K., Chua, L. A. V., Mak, T. M., Foo, K., Muhammad, I. R., Low, C. K. K., Ma, S., Ooi, S. P. L., Lin, R. T. P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.03.054 · Cited by 15
Young‐Xu, Y., Snider, J. T., Mahmud, S. M., Russo, E. M., van Aalst, R., Thommes, E. W., Lee, J. K. H., & Chit, A. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.19.1900401 · Cited by 12
Mira‐Iglesias, A., López‐Labrador, F. X., García‐Rubio, J., Mengual‐Chuliá, B., Tortajada‐Girbés, M., Mollar‐Maseres, J., Carballido‐Fernández, M., Schwarz‐Chavarri, G., Puig‐Barberà, J., & Díez‐Domingo, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031129 · Cited by 11
Metadata
- Authors
- Grohskopf, L. A., Blanton, L. H., Ferdinands, J. M., Chung, J. R., Broder, K. R., Talbot, H. K., Morgan, R. L., & Fry, A. M.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2022-08-26
- Volume
- 71
- Issue
- 1
- Pages
- 1-28
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W4293102569
- Cited by
- 320
- References
- 105
- FWCI
- 42.87
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.